As of 2025-12-23, the Relative Valuation of Sigilon Therapeutics, Inc. (SGTX) is (180.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.47 USD, the upside of Sigilon Therapeutics, Inc. based on Relative Valuation is -902.3%.
The range of the Relative Valuation is (131.83) - (227.39) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 15.4x | 12.2x |
| Forward P/E multiples | 8.9x - 15.7x | 12.3x |
| Fair Price | (131.83) - (227.39) | (180.28) |
| Upside | -686.7% - -1112.0% | -902.3% |
| Date | P/E |